Jefferies Sees Solid Upcoming Q1 Results from HP (HPQ)
Get Alerts HPQ Hot Sheet
Price: $36.58 --0%
Rating Summary:
14 Buy, 24 Hold, 1 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 15 | Down: 19 | New: 37
Rating Summary:
14 Buy, 24 Hold, 1 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 15 | Down: 19 | New: 37
Join SI Premium – FREE
Jefferies commented on Hewlett-Packard (NYSE: HPQ) ahead of Q1 results on February 22nd, after the market closes. The firm sees a solid quarter.
The analyst states, "We believe both Dell (Nasdaq: DELL) and HPQ had solid quarters relative to their guidance due to: 1) limited HDD impact; 2) data center demand helping their enterprise businesses; 3) Okay service bookings. The worst-case scenario of a substantial CQ1 HDD shortfall now appears unlikely. We expect relatively optimistic guidance from Dell and HP."
Jefferies maintained a Buy rating and $35 price target on HPQ. The firm's Q1 EPS estimate remains at $0.89, just above the consensus of $0.87.
For an analyst ratings summary and ratings history on Hewlett-Packard click here. For more ratings news on Hewlett-Packard click here.
Shares of Hewlett-Packard closed at $29.08 yesterday.
The analyst states, "We believe both Dell (Nasdaq: DELL) and HPQ had solid quarters relative to their guidance due to: 1) limited HDD impact; 2) data center demand helping their enterprise businesses; 3) Okay service bookings. The worst-case scenario of a substantial CQ1 HDD shortfall now appears unlikely. We expect relatively optimistic guidance from Dell and HP."
Jefferies maintained a Buy rating and $35 price target on HPQ. The firm's Q1 EPS estimate remains at $0.89, just above the consensus of $0.87.
For an analyst ratings summary and ratings history on Hewlett-Packard click here. For more ratings news on Hewlett-Packard click here.
Shares of Hewlett-Packard closed at $29.08 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Assicurazioni Generali SpA (G:IM) (ARZGY) to Overweight
- Morgan Stanley Downgrades Allianz SE (ALV:GR) (AZSEY) to Equalweight
- Raymond James Resumes Acadia Pharmaceuticals (ACAD) at Market Perform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!